A study conducted at a tertiary care hospital in South Korea showed prescription of drugs used in the treatment of infections with multidrug-resistant bacteria, including carbapenems, glycopeptides, oxazolidinones, polymyxins and glycylcyclines, showed a trend toward an increase between 2004 to 2013.
← all excerpts
Polymyxin for treatment of ventilator-associated pneumonia in a setting of high carbapenem resistance.
1
—
—